Literature DB >> 33825168

Neonatal androgenization in rats affects oocyte maturation.

Gabriel Anesetti1, Rebeca Chávez-Genaro2.   

Abstract

Androgens are relevant in order to achieve a normal growth and maturation of the follicle and oocyte, since both excess and absence of androgens may affect the correct ovarian function. The current study analyzes the impact of neonatal androgenization in the first ovulation and oocyte maturation in response to exogenous gonadotrophin stimulation. Neonatal rats were daily treated with testosterone, dihydrotestosterone, or vehicle during follicle assembly period (days 1 to 5). At juvenile period, rats were stimulated sequentially with PMSG and hCG. Ovulation, ovarian histology, hormonal milieu, morphological characteristics of meiotic spindle, and in vitro fertilization rate in oocytes were analyzed. Our data shows that oocytes from androgenized rats displayed a major proportion of aberrant spindles and altered meiotic advance that control animals. These alterations were accompanied with an increase in both fertilization rate and aberrant embryos after 48 h of culture. Our findings showed a direct impact of neonatal androgens on oocyte development; their effects may be recognized at adulthood, supporting the idea of a programming effect exerted by neonatal androgens. These results could be relevant to explain the low fertility rate seen in polycystic ovary syndrome patients after in vitro fertilization procedures.
© 2021. Society for Reproductive Investigation.

Entities:  

Keywords:  Androgens; Developmental programming; Meiotic spindle; Ovulation

Mesh:

Substances:

Year:  2021        PMID: 33825168     DOI: 10.1007/s43032-021-00559-6

Source DB:  PubMed          Journal:  Reprod Sci        ISSN: 1933-7191            Impact factor:   3.060


  1 in total

1.  Structural and functional changes in rat uterus induced by neonatal androgenization.

Authors:  Rebeca Chávez-Genaro; Agustina Toledo; Karina Hernández; Gabriel Anesetti
Journal:  J Mol Histol       Date:  2022-10-06       Impact factor: 3.156

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.